Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
55
days
Emerging Pharmacological Strategies for Trigeminal Neuralgia
AuthorsJuliana Geremias Chichorro; Victor Augusto Benedicto dos Santos; Gerald W. Zamponi
Affiliations1. Department of Pharmacology, Biological Sciences Sector, Federal University of Parana, Curitiba, Brazil; 2. Department of Clinical Neurosciences, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada
263
days
Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysis
AuthorsKeisuke Kusudo; Yuki Mashima; Hideaki Yasuda; Teruomi Iyo; Hiroyoshi Takeuchi
Affiliations1. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; 2. Department of Neuropsychiatry, National Hospital Organization Chiba Medical Center, Chiba, Japan; 3. Department of Psychiatry, Sekito Hospital, Shimane, Japan; 4. Department of Psychiatry, Chiba Aoba Municipal Hospital, Chiba, Japan; 5. Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan
141
days
Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD
AuthorsMonica Margoni; Paolo Preziosa; Maria A. Rocca; Massimo Filippi
Affiliations1. Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; 2. Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; 3. Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; 4. Vita-Salute San Raffaele University, Milan, Italy; 5. Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy
224
days
Tenecteplase Beyond the 4.5-h Window for Patients with Acute Ischemic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials
AuthorsOcílio Ribeiro Gonçalves; Luca Scarcia; João Gabriel Silva Portela; Gabriel Soares Bruno Santos; Leonardo Januario Campos Cardoso; Anderson Matheus Pereira da Silva; Altair Pereira de Melo Neto; João Victor Sanders; Luciano Falcão; Mariana Letícia de Bastos Maximiano; Luis Felipe Vieira Nunes Porto; Frédéric Clarençon; Thanh Nguyen; Kelson James Almeida; Ahmet Günkan
Affiliations1. Department of Medicine, Federal University of Piauí (UFPI), Teresina, Brazil; 2. Diagnostic and Interventional Neuroradiology, Henri Mondor Hospital, Créteil, France; 3. School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil; 4. Department of Physiology and Pharmacology, Federal University of Pernambuco, Recife, Brazil; 5. Department of Medicine, Federal University of Roraima, Boa Vista, Brazil; 6. Brain and Spine Institute, Advocate Health, Chicago, USA; 7. Department of Medicine, Bahiana School of Health and Public Health, Salvador, Brazil; 8. Deparment of Medicine, Federal Fluminense University, Rio de Janeiro, Brazil; 9. Department of Neuroradiology, Pitié-Salpêtrière Hospital, APHP, Paris, France; 10. Sorbonne Université, Paris, France; 11. Department of Neuroradiology, Sorbonne University, Paris, France; 12. Department of Neurology, Boston University School of Medicine, Boston, USA; 13. Division of Vascular and Interventional Radiology, Department of Medical Imaging, University of Arizona, Tucson, USA
274
days
Managing Dermatologic Delusional Disorders: A US Psychodermatology Perspective for Clinicians
AuthorsAndrea Leung; John Koo
Affiliations1. Department of Dermatology, University of California, San Francisco, San Francisco, USA
85
days
Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review
AuthorsEdward Willow; Aditi Chaudhri; Linda Hasman; Rajbala Thakur; Michael Scott; Robert H. Dworkin
Affiliations1. Department of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, Rochester, USA; 2. Department of Medicine, University of Rochester Medical Center, Rochester, USA; 3. Department of Physical Medicine and Rehabilitation, University of Rochester Medical Center, Rochester, USA; 4. Department of Neurology, University of Rochester Medical Center, Rochester, USA
154
days
A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use
AuthorsAvia Merenlender Wagner; Itay Perlstein; Pavel Farkas; Michael Lamson; Pippa Loupe; Ofer Spiegelstein; Attila Kalmanczhelyi; Ryan Tiver; Kelli R. Franzenburg; Eran Harary; Anna Elgart
Affiliations1. Teva Pharmaceutical Industries Ltd., Quantitative Pharmacology and Biosimilar Sciences, Netanya, Israel; 2. Magic Wand Research LLC, Philadelphia, USA; 3. Teva PLIVA Croatia Ltd, Research and Development, Zagreb, Croatia; 4. Nuventra Pharma Sciences, Pharmacokinetics and Clinical Pharmacology, Carrboro, USA; 5. Teva Branded Pharmaceutical Products LLC, West Chester, USA; 6. Teva Pharmaceutical Works Private Ltd., Debrecen, Hungary
194
days
Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase ® Data
AuthorsPauline Schiro; Mónica Gálvez Pacoricona; Adèle Le Guilloux; Amélia Déguilhem; Sonia Merad; Emilie Bouquet; Marine Auffret; Joëlle Micallef; Maryse Lapeyre-Mestre; Emilie Jouanjus
Affiliations1. Pharmacovigilance Center, Department of Medical Pharmacology, Toulouse University Hospital, Toulouse, France; 2. University of Toulouse, Toulouse, France; 3. CERPOP, Inserm-University of Toulouse, Toulouse, France; 4. University of Paris Saclay, Paris, France; 5. University of Poitiers, INSERM, Poitiers University Hospital, Clinical Investigation Center CIC 1402, Poitiers, France; 6. Addictovigilance Center, Department of Clinical Pharmacology, Poitiers University Hospital, Poitiers, France; 7. Service Hospitalo-Universitaire de Pharmacotoxicologie, Hospices Civils de Lyon, Lyon, France; 8. UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Université Lyon 1, Lyon, France; 9. The Institut de Neurosciences des Systèmes INS, UMR1106, Aix Marseille University, Marseille, France; 10. Addictovigilance Center, Pharmacovigilance Center, Department of Clinical Pharmacology and Drug Surveillance, Marseille University Hospital, Marseille, France; 11. PEPSS Team (Pharmacology Population, cohortS, biobankS), CIC Inserm 1436, University of Toulouse, Toulouse, France; 12. Addictovigilance Center, Department of Medical Pharmacology, Toulouse University Hospital, Toulouse, France
239
days
The Role of Long-Acting Injectable Antipsychotics in the Early Treatment of Schizophrenia
AuthorsSarah Jane Harrison; Jose Antunes; Karl Knight; Karen Johnston; Jordy Mehawej; Pedro Sanchez; Christoph U. Correll
Affiliations1. Johnson and Johnson, Toronto, Canada; 2. Johnson & Johnson, Barcarena, Portugal; 3. Johnson & Johnson, Titusville, USA; 4. Hospital of Zamudio, Red de Salud Mental de Bizkaia, Biscay, Spain; 5. School of Medicine, University of Deusto, Bilbao, Spain; 6. The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA; 7. Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, USA; 8. The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Northwell Health, New Hyde Park, USA; 9. Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany; 10. German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany
138
days
Cannabidiol Use in Developmental and Epileptic Encephalopathies: A Syndrome- and Age-Stratified Systematic Review and Meta-analysis
AuthorsHelen Michaela de Oliveira; Pandoara Eloa Oliveira Fonseca; José Eduardo Trejo Elías; Guilherme Oliveira de Paula; Amanda Pinzon Blaskoski; Pablo Ramon Fruett da Costa
Affiliations1. Department of Medicine, Federal University of Mato Grosso, Sinop, Brazil; 2. Department of Medicine, Federal University of Campina Grande, Campina Grande, Brazil; 3. Department of Medicine, Universidad Panamericana, Mexico City, Mexico; 4. Department of Functional Neurosurgery, Sinedor Clinic, Sinop, Brazil
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days